Gesynta Pharma Funding: $67M Raised, Series B (2025)
Gesynta Pharma is based in Stockholm, Sweden. It has raised $67M in total funding. Latest round: Series B.
Gesynta Pharma funding overview
Gesynta Pharma is based in Stockholm, Sweden. Gesynta Pharma has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2025. The round record for Gesynta Pharma runs through 2025; nothing later has been disclosed. Investors on record include Innovestor Life Science, Hadean Ventures, Industrifonden, Linc, Foreground Capital, Catalyze Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
Gesynta Pharma at a glance
Total raised
$67M
Latest round
Series B
Latest round date
January 2025
Headquarters
Stockholm, Sweden
Notable investors
Innovestor Life Science, Hadean Ventures, Industrifonden, Linc, Foreground Capital, Catalyze Capital, Stephen Industries, Amboy Street Ventures
Frequently asked about Gesynta Pharma funding
How much has Gesynta Pharma raised?
Gesynta Pharma has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Gesynta Pharma?
Innovestor Life Science, Hadean Ventures, Industrifonden, Linc, Foreground Capital, Catalyze Capital are named among the investors backing Gesynta Pharma.
What was the latest Gesynta Pharma funding round?
The most recent disclosed round is a Series B, announced in January 2025.
Where is Gesynta Pharma based?
Gesynta Pharma is based in Stockholm, Sweden.
When did Gesynta Pharma last raise?
The last disclosed Gesynta Pharma round closed in January 2025 at Series B.
Totals shown for Gesynta Pharma aggregate every disclosed round on file. To see how that compares, browse the companies in Stockholm and the investors behind them below.
